Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MMP9 | P14780 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3441107 | 0.80 | TDP1 (0.49) | KDM4EUSP2ALDH1A1LMNAMMP9 | |
| SCHEMBL166112 | 0.73 | — | — | |
| SCHEMBL3441325 | 0.73 | TSHR (0.43) | KDM4EUSP2ALDH1A1LMNAMMP9 | |
| SCHEMBL19506911 | 0.72 | TDP1 (0.38) | ALDH1A1TSHR | |
| SCHEMBL10011406 | 0.71 | — | — | |
| SCHEMBL33444 | 0.70 | — | — | |
| SCHEMBL27498554 | 0.70 | — | — | |
| SCHEMBL3441164 | 0.70 | GAA (0.48) | KDM4EUSP2ALDH1A1LMNAMMP9 | |
| SCHEMBL10012772 | 0.70 | TDP1 (0.31) | — | |
| SCHEMBL2697240 | 0.70 | ALDH1A1 (0.39) | USP2ALDH1A1LMNAALOX15TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8580429-B2 | Non-aqueous electrolyte for a lithium battery, lithium battery wherein said electrolyte is used, and hydroxy-acid derivative for use in said electrolyte | UBE INDUSTRIES, LTD. (JP) | 2013-11-12 | — | — | US | disclosed |
| EP-2251926-B1 | NON-AQUEOUS ELECTROLYTE FOR A LITHIUM BATTERY, LITHIUM BATTERY USING SAID ELECTROLYTE, AND HYDROXY-ACID DERIVATIVE FOR USE IN SAID ELECTROLYTE | UBE INDUSTRIES (JP) | 2013-09-11 | — | — | EP | disclosed |
| US-20110064998-A1 | NON-AQUEOUS ELECTROLYTE FOR A LITHIUM BATTERY, LITHIUM BATTERY WHEREIN SAID ELECTROLYTE IS USED, AND HYDROXY-ACID DERIVATIVE FOR USE IN SAID ELECTROLYTE | UBE INDUSTRIES, LTD. (JP) | 2011-03-17 | — | — | US | disclosed |
| EP-2251926-A1 | NON-AQUEOUS ELECTROLYTE FOR A LITHIUM BATTERY, LITHIUM BATTERY WHEREIN SAID ELECTROLYTE IS USED, AND HYDROXY-ACID DERIVATIVE FOR USE IN SAID ELECTROLYTE | Ube Industries, Ltd. (JP) | 2010-11-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110064998-A1 | NON-AQUEOUS ELECTROLYTE FOR A LITHIUM BATTERY, LITHIUM BATTERY WHEREIN SAID ELECTROLYTE IS USED, AND HYDROXY-ACID DERIVATIVE FOR USE IN SAID ELECTROLYTE | HCN2, SLC9A1, SLC9B2 | KDM4E 141/4885USP2 4764/4885ALDH1A1 640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.